Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Health Services Needs and Demand × Head & Neck × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1

Interventions

pembrolizumab 159 Cisplatin 139 Carboplatin 68 Radiotherapy 67 Nivolumab 62 Cetuximab 61 Radiotherapy, Intensity-Modulated 54 Magnetic Resonance Spectroscopy 51 Paclitaxel 50 Docetaxel 49 Specimen Handling 36 Radiation 31 Gemcitabine 31 Fluorouracil 29 Biopsy 24 Surveys and Questionnaires 23 toripalimab 22 Surgical Procedures, Operative 21 Drug Therapy 21 Platinum 20 atezolizumab 19 Capecitabine 19 1,2-diaminocyclohexaneplatinum II citrate 19 Standard of Care 18 Ipilimumab 17 Chemoradiotherapy 17 tislelizumab 16 durvalumab 16 cemiplimab 16 lenvatinib 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06347185 2025-07-17

SupCare

European Organisation for Research and Treatment of Cancer - EORTC

Phase NA Withdrawn

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡